PROVECTUS BIOPHARMACEUTICALS, INC.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2003 | — | — | $-3.2M |
| FY2004 | — | — | $-4.3M |
| FY2005 | — | — | $-11.8M |
| FY2006 | — | — | $-8.9M |
| FY2007 | — | — | $-10.0M |
| FY2008 | — | — | $-10.3M |
| FY2009 | — | $-12.3M | $-12.3M |
| FY2010 | — | $-20.7M | $-18.6M |
| FY2011 | $0 | $-21.4M | $-19.4M |
| FY2012 | $0 | $-14.3M | $-12.6M |
| FY2013 | $0 | $-13.0M | $-27.7M |
| FY2014 | $0 | $-12.6M | $-10.2M |
| FY2015 | $0 | $-24.7M | $-24.5M |
| FY2016 | — | $-24.5M | $-24.4M |
| FY2017 | — | $-13.3M | $-13.5M |
| FY2018 | — | $-8.1M | $-8.2M |
| FY2019 | — | $-6.3M | $-6.9M |
| FY2020 | — | $-5.0M | $-6.7M |
| FY2021 | — | $-4.7M | $-5.5M |
| FY2022 | $989.0K | $-3.4M | $-3.6M |
| FY2023 | $557.7K | $-2.9M | $-3.1M |
| FY2024 | $617.1K | $-4.5M | $-4.7M |
| FY2025 | $336.1K | $-5.3M | $-5.4M |